Found: 37
Select item for more details and to access through your institution.
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2768, doi. 10.3390/jcm13102768
- By:
- Publication type:
- Article
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 1964, doi. 10.3390/jcm13071964
- By:
- Publication type:
- Article
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine.
- Published in:
- Toxins, 2024, v. 16, n. 2, p. 106, doi. 10.3390/toxins16020106
- By:
- Publication type:
- Article
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 386, doi. 10.3390/jcm13020386
- By:
- Publication type:
- Article
Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study.
- Published in:
- Neurology International, 2023, v. 15, n. 3, p. 1117, doi. 10.3390/neurolint15030069
- By:
- Publication type:
- Article
Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.
- Published in:
- Toxins, 2023, v. 15, n. 9, p. 539, doi. 10.3390/toxins15090539
- By:
- Publication type:
- Article
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4526, doi. 10.3390/jcm12134526
- By:
- Publication type:
- Article
A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 2217, doi. 10.1007/s12325-022-02388-8
- By:
- Publication type:
- Article
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1435, doi. 10.1111/ene.15740
- By:
- Publication type:
- Article
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 9, p. 3218, doi. 10.3390/jcm12093218
- By:
- Publication type:
- Article
A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 4, p. 734, doi. 10.3390/medicina59040734
- By:
- Publication type:
- Article
Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 1, p. 31, doi. 10.3390/medicina59010031
- By:
- Publication type:
- Article
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine.
- Published in:
- Toxins, 2022, v. 14, n. 12, p. 847, doi. 10.3390/toxins14120847
- By:
- Publication type:
- Article
Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine.
- Published in:
- Toxins, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/toxins14070434
- By:
- Publication type:
- Article
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis.
- Published in:
- Acta Neurologica Scandinavica, 2022, v. 145, n. 6, p. 676, doi. 10.1111/ane.13600
- By:
- Publication type:
- Article
Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis.
- Published in:
- Toxins, 2022, v. 14, n. 5, p. 296, doi. 10.3390/toxins14050296
- By:
- Publication type:
- Article
CADASIL in Greece: Mutational spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 3, p. 810, doi. 10.1111/ene.15180
- By:
- Publication type:
- Article
VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case–Control Study in a Southeastern European Caucasian Population.
- Published in:
- Journal of Molecular Neuroscience, 2022, v. 72, n. 2, p. 382, doi. 10.1007/s12031-021-01892-w
- By:
- Publication type:
- Article
Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.
- Published in:
- Journal of Molecular Neuroscience, 2022, v. 72, n. 2, p. 393, doi. 10.1007/s12031-021-01913-8
- By:
- Publication type:
- Article
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 67, doi. 10.3390/jcm10010067
- By:
- Publication type:
- Article
Meta‐analysis of melatonin levels in cluster headache—Review of clinical implications.
- Published in:
- Acta Neurologica Scandinavica, 2020, v. 142, n. 4, p. 356, doi. 10.1111/ane.13317
- By:
- Publication type:
- Article
Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta‐Analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 7, p. 1273, doi. 10.1111/head.13828
- By:
- Publication type:
- Article
Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population.
- Published in:
- Journal of Molecular Neuroscience, 2020, v. 70, n. 3, p. 467, doi. 10.1007/s12031-019-01439-0
- By:
- Publication type:
- Article
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0918-3
- By:
- Publication type:
- Article
A new era in headache treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cluster headache in Greece: an observational clinical and demographic study of 302 patients.
- Published in:
- Journal of Headache & Pain, 2016, v. 17, n. 1, p. 1, doi. 10.1186/s10194-016-0683-0
- By:
- Publication type:
- Article
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
- Published in:
- Journal of Headache & Pain, 2016, v. 17, n. 1, p. 1, doi. 10.1186/s10194-016-0676-z
- By:
- Publication type:
- Article
The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2015, v. 8, n. 4, p. 160, doi. 10.1177/1756285615585918
- By:
- Publication type:
- Article
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.
- Published in:
- SAGE Open Medicine, 2015, v. 3, p. 1, doi. 10.1177/2050312115587795
- By:
- Publication type:
- Article
Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine.
- Published in:
- Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 429, doi. 10.2147/NDT.S27456
- By:
- Publication type:
- Article
Headache in Systemic Lupus Erythematosus vs Multiple Sclerosis: A Prospective Comparative Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 9, p. 1398, doi. 10.1111/j.1526-4610.2011.01962.x
- By:
- Publication type:
- Article
An Observational Trial to Investigate the Efficacy and Tolerability of Levetiracetam in Trigeminal Neuralgia.
- Published in:
- Headache: The Journal of Head & Face Pain, 2010, v. 50, n. 8, p. 1371, doi. 10.1111/j.1526-4610.2010.01743.x
- By:
- Publication type:
- Article
The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study.
- Published in:
- Neurological Sciences, 2010, v. 31, n. 3, p. 259, doi. 10.1007/s10072-009-0170-3
- By:
- Publication type:
- Article
Role of Antiepileptic Drugs as Preventive Agents for Migraine.
- Published in:
- CNS Drugs, 2010, v. 24, n. 1, p. 21, doi. 10.2165/11310970-000000000-00000
- By:
- Publication type:
- Article
Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continua.
- Published in:
- Journal of Headache & Pain, 2005, v. 6, n. 3, p. 156, doi. 10.1007/s10194-005-0172-3
- By:
- Publication type:
- Article